News

The following companies are expected to report earnings prior to market open on 02/26/2024. Visit our Earnings Calendar for a full list of expected earnings releases.

Fidelity National Information Services, Inc. (FIS)is reporting for the quarter ending December 31, 2023. The financial transactions company's consensus earnings per share forecast from the 10 analysts that follow the stock is $0.95. This value represents a 44.44% decrease compared to the same quarter last year. In the past year FIS and beat the expectations the other three quarters. Zacks Investment Research reports that the 2023 Price to Earnings ratio for FIS is 18.96 vs. an industry ratio of 11.80, implying that they will have a higher earnings growth than their competitors in the same industry.

Public Service Enterprise Group Incorporated (PEG)is reporting for the quarter ending December 31, 2023. The electric power utilities company's consensus earnings per share forecast from the 5 analysts that follow the stock is $0.53. This value represents a 17.19% decrease compared to the same quarter last year. In the past year PEG and beat the expectations the other three quarters. Zacks Investment Research reports that the 2023 Price to Earnings ratio for PEG is 17.40 vs. an industry ratio of 17.50.

Domino's Pizza Inc (DPZ)is reporting for the quarter ending December 31, 2023. The restaurant company's consensus earnings per share forecast from the 12 analysts that follow the stock is $4.36. This value represents a 1.58% decrease compared to the same quarter last year. In the past year DPZ and beat the expectations the other three quarters. Zacks Investment Research reports that the 2023 Price to Earnings ratio for DPZ is 29.48 vs. an industry ratio of 39.80.

Elanco Animal Health Incorporated (ELAN)is reporting for the quarter ending December 31, 2023. The medical (outpatient/home care) company's consensus earnings per share forecast from the 8 analysts that follow the stock is $0.10. This value represents a 47.37% decrease compared to the same quarter last year. In the past year ELAN and beat the expectations the other three quarters. Zacks Investment Research reports that the 2023 Price to Earnings ratio for ELAN is 17.75 vs. an industry ratio of 16.90, implying that they will have a higher earnings growth than their competitors in the same industry.

Pilgrim's Pride Corporation (PPC)is reporting for the quarter ending December 31, 2023. The meat product company's consensus earnings per share forecast from the 1 analyst that follows the stock is $0.42. This value represents a 185.71% increase compared to the same quarter last year. In the past year PPC and beat the expectations the other two quarters. Zacks Investment Research reports that the 2023 Price to Earnings ratio for PPC is 18.80 vs. an industry ratio of 9.80, implying that they will have a higher earnings growth than their competitors in the same industry.

Alpha Metallurgical Resources, Inc. (AMR)is reporting for the quarter ending December 31, 2023. The mining company's consensus earnings per share forecast from the 1 analyst that follows the stock is $8.78. This value represents a 34.33% decrease compared to the same quarter last year. AMR missed the consensus earnings per share in the 4th calendar quarter of 2022 by -14.07%. Zacks Investment Research reports that the 2023 Price to Earnings ratio for AMR is 8.70 vs. an industry ratio of -3.20, implying that they will have a higher earnings growth than their competitors in the same industry.

Freshpet, Inc. (FRPT)is reporting for the quarter ending December 31, 2023. The food company's consensus earnings per share forecast from the 7 analysts that follow the stock is $0.09. This value represents a 250.00% increase compared to the same quarter last year. FRPT missed the consensus earnings per share in the 1st calendar quarter of 2023 by -30%. The "days to cover" for this stock exceeds 15 days. Zacks Investment Research reports that the 2023 Price to Earnings ratio for FRPT is -108.78 vs. an industry ratio of 12.50.

Surgery Partners, Inc. (SGRY)is reporting for the quarter ending December 31, 2023. The medical services company's consensus earnings per share forecast from the 3 analysts that follow the stock is $0.28. This value represents a 27.27% increase compared to the same quarter last year. In the past year SGRY and beat the expectations the other three quarters. The "days to cover" for this stock exceeds 10 days. Zacks Investment Research reports that the 2023 Price to Earnings ratio for SGRY is 45.01 vs. an industry ratio of 20.00, implying that they will have a higher earnings growth than their competitors in the same industry.

Itron, Inc. (ITRI)is reporting for the quarter ending December 31, 2023. The electrical test equipment company's consensus earnings per share forecast from the 8 analysts that follow the stock is $0.75. This value represents a 5.63% increase compared to the same quarter last year. In the past year ITRI and beat the expectations the other three quarters. Zacks Investment Research reports that the 2023 Price to Earnings ratio for ITRI is 26.16 vs. an industry ratio of 36.40.

Krystal Biotech, Inc. (KRYS)is reporting for the quarter ending December 31, 2023. The biomedical (gene) company's consensus earnings per share forecast from the 4 analysts that follow the stock is $-0.52. This value represents a 58.40% increase compared to the same quarter last year. The last two quarters KRYS had negative earnings surprises; the latest report they missed by -197.62%. Zacks Investment Research reports that the 2023 Price to Earnings ratio for KRYS is -28.78 vs. an industry ratio of -1.70.

Playtika Holding Corp. (PLTK)is reporting for the quarter ending December 31, 2023. The gaming company's consensus earnings per share forecast from the 5 analysts that follow the stock is $0.18. This value represents a 25.00% decrease compared to the same quarter last year. In the past year PLTK has met analyst expectations once and beat the expectations the other two quarters. Zacks Investment Research reports that the 2023 Price to Earnings ratio for PLTK is 9.18 vs. an industry ratio of 4.10, implying that they will have a higher earnings growth than their competitors in the same industry.

BioCryst Pharmaceuticals, Inc. (BCRX)is reporting for the quarter ending December 31, 2023. The drug company's consensus earnings per share forecast from the 6 analysts that follow the stock is $-0.24. This value represents a 36.84% increase compared to the same quarter last year. BCRX missed the consensus earnings per share in the 4th calendar quarter of 2022 by -100%. The "days to cover" for this stock exceeds 11 days. Zacks Investment Research reports that the 2023 Price to Earnings ratio for BCRX is -6.19 vs. an industry ratio of -5.60.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.